Research and Markets: Threshold Pharmaceuticals Inc: Premium Company Profile Contains Corporate Strategy, Value Chain Presence And SWOT Analysis

Business Wire, April 11, 2008

DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c88514) has announced the addition of "Threshold Pharmaceuticals Inc: Premium Company Profile" to their offering.

Threshold Pharmaceuticals is a biotechnology company focused on the discovery, development and commercialization of drugs based on metabolic targeting, an approach that targets fundamental differences in metabolism between normal and certain diseased cells. The company uses metabolic targeting technology to identify new product candidates, therapeutic indications and technologies.

Scope

- Contains corporate strategy, value chain presence and SWOT Analysis

- Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors

- Includes information on suppliers/ partners, shareholding structure and key employees with biographies

Highlights of this title

Threshold Pharmaceuticalss lead candidate is glufosfamide which is being developed as second line treatment for metastatic pancreatic cancer (Phase III), platinum resistant ovarian cancer (Phase II), soft tissue sarcoma (Phase II); and small cell lung cancer (Phase II).

The company derives its entire revenues from a collaboration agreement with MediBIC for the development of glufosfamide for the treatment of pancreatic cancer in certain Asian countries, including Japan, South Korea, India, China, Taiwan and Hong Kong.

Threshold Pharmaceuticals is expected to witness an absolute decline of -$1 million during the forecast period 2006-2010. This would be driven by the failure of glufosfamide in meeting the primary endpoint in the Phase III trial in patients with metastatic pancreatic cancer who had relapsed after gemcitabine chemotherapy.

Key reasons to purchase this title

- Access all the important information and analysis on the company in a single report

- Understand companys strengths, weaknesses, opportunities and threats along with business strategy and value chain

- Gain access to companys adjusted five year financial data along with key ratios and market capitalization

For more information, visit http://www.researchandmarkets.com/reports/c88514

Source: Datamonitor